What Merus N.V.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 11 |
| Sells | 0 | 2 |
| Total trades | 0 | 40 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 50,452 |
| Disposed | 0 | 333,770 |
| Net activity | +0 | −283,318 |
Common stock only — 11 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Genmab A/S | 10% owner | Dec 29 | Open-market buy · P | −75,867,199 | $97.00 | −$7.36B | 0 |
| Genmab A/S | 10% owner | Dec 29 | Open-market buy · P | +1,052,806 | $97.00 | +$102M | 73,884,293 |
| Genmab A/S | 10% owner | Dec 26 | Open-market buy · P | +142,610 | $97.00 | +$13.8M | 72,828,509 |
| Genmab A/S | 10% owner | Dec 26 | Open-market buy · P | +2,978 | $97.00 | +$289K | 72,831,487 |
| Genmab A/S | 10% owner | Dec 24 | Open-market buy · P | +96,082 | $97.00 | +$9.32M | 72,685,899 |
| Genmab A/S | 10% owner | Dec 23 | Open-market buy · P | +561,042 | $97.00 | +$54.4M | 72,589,817 |
| Genmab A/S | 10% owner | Dec 22 | Open-market buy · P | +15,710 | $97.00 | +$1.52M | 72,028,775 |
| Genmab A/S | 10% owner | Dec 19 | Open-market buy · P | +66,264 | $97.00 | +$6.43M | 72,013,065 |
| Genmab A/S | 10% owner | Dec 18 | Open-market buy · P | +212,177 | $97.00 | +$20.6M | 71,946,801 |
| Genmab A/S | 10% owner | Dec 17 | Open-market buy · P | +150,795 | $97.00 | +$14.6M | 71,734,624 |
| Genmab A/S | 10% owner | Dec 16 | Open-market buy · P | +120,752 | $97.00 | +$11.7M | 71,583,829 |
| Iwicki Mark T | Director | Dec 12 | Tender Offer · U | −73,576 | $97.00 | −$7.14M | 0 |
| Shuman Harry | VP Controller, PAO | Dec 12 | Tender Offer · U | −11,002 | $97.00 | −$1.07M | 0 |
| Lundberg Sven Ante | President, CEO & PEO | Dec 12 | Tender Offer · U | −9,192 | $97.00 | −$892K | 0 |
| Lundberg Sven Ante | President, CEO & PEO | Dec 12 | Tender Offer · U | −9,192 | $97.00 | −$892K | 0 |
| Lundberg Sven Ante | President, CEO & PEO | Dec 12 | Tender Offer · U | −9,191 | $97.00 | −$892K | 0 |
| Lundberg Sven Ante | President, CEO & PEO | Dec 12 | Tender Offer · U | −9,191 | $97.00 | −$892K | 0 |
| Lundberg Sven Ante | President, CEO & PEO | Dec 12 | Tender Offer · U | −16,372 | $97.00 | −$1.59M | 0 |
| Lundberg Sven Ante | President, CEO & PEO | Dec 12 | Tender Offer · U | −30,297 | $97.00 | −$2.94M | 0 |
| Shuman Harry | VP Controller, PAO | Nov 26 | Open-market sale · S | −1,700 | $96.10 | −$163K | 11,002 |
Loading...